Suscribirse

Intensive therapeutic education strategy for patients with acute heart failure (EduStra-HF): Design of a randomized controlled trial - 17/10/24

Doi : 10.1016/j.acvd.2024.04.006 
Stéphanie Jullien a, Sylvie Lang b, Manon Gerard a, Laurie Soulat-Dufour b, c, Ernesto Brito b, Emilie Ocokoljic b, Thierry Laperche d, Jean-Louis Georges e, Christelle Diakov f, Olivier Belliard g, Fabrice Larrazet h, Sophie Bataille i, Patrick Assyag a, Ariel Cohen a, b, c,

on behalf of the EduStra-HF investigators

a RESICARD, Heart Failure Network, 75011 Paris, France 
b Department of Cardiology, Saint-Antoine and Tenon Hospitals, AP-HP, Sorbonne Université, 75012 Paris, France 
c INSERM UMRS 1166, Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne Université, 75012 Paris, France 
d Department of Cardiology, Centre Cardiologique du Nord, 93200 Saint-Denis, France 
e Department of Cardiology, Centre Hospitalier de Versailles, 78150 Le Chesnay-Rocquencourt, France 
f Department of Cardiology, Montsouris Mutualist Institute, 75014 Paris, France 
g Department of Cardiology, Ambroise Paré Clinic, 92200 Neuilly-sur-Seine, France 
h Department of Cardiology, Mont-Louis Clinic, 75011 Paris, France 
i Ile-de-France Regional Health Agency, 93200 Saint-Denis, France 

Corresponding author. Service de Cardiologie, Hôpitaux Saint-Antoine/Tenon, AP–HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris cedex 12, France.Service de Cardiologie, Hôpitaux Saint-Antoine/Tenon, AP–HP184, rue du Faubourg-Saint-AntoineParis cedex 1275012France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Graphical abstract




El texto completo de este artículo está disponible en PDF.

Highlights

EduStra-HF will enrol patients hospitalized for acute heart failure.
Patients will be randomized to usual care or an intensive education strategy.
Primary outcome is first hospitalization for heart failure during 1-year follow-up.
Secondary outcomes include quality of life, death and cost-effectiveness.

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Heart failure is associated with reduced quality of life, hospitalizations, death and high healthcare costs. Despite care improvements, the rehospitalization rate after an acute heart failure episode, especially for acute heart failure, remains high.

Methods

The Education Strategy for patients with acute Heart Failure (EduStra-HF; ClinicalTrials.gov Identifier NCT03035123) study will randomize patients admitted for acute heart failure in six French hospitals to usual care (control) or therapeutic education (intervention). All patients will be evaluated at baseline and will meet with a therapeutic education nurse before discharge. Those in the usual care arm will have standard appointments with their cardiologist and general practitioner. Those in the intervention arm will have an intensive follow-up schedule of phone calls, home visits and text messages from the therapeutic education nurses, plus cardiologist visits. Patients will be stratified by discharge location (home or cardiac rehabilitation centre) before randomization, and will be followed up for 1 year. The primary outcome will be the readmission rates for acute heart failure during 1 year in the two groups. Secondary outcomes will include: quality of life; time from inclusion to first readmission for acute heart failure; non-heart failure cardiovascular rehospitalization rates; length of stay for heart failure; cardiovascular and all-cause death; rates of patients receiving optimal medical therapies; evolution of knowledge about heart failure; and cost-effectiveness.

Conclusions

This study will assess the efficacy and feasibility of a standardized management strategy for the care and follow-up of patients discharged after hospitalization for acute heart failure. The EduStra-HF strategy will combine various nurse care methods to help prevent rehospitalization.

El texto completo de este artículo está disponible en PDF.

Keywords : Heart failure, Therapeutic education, Quality of life, Transitional care, Nursing care


Esquema


 X post (Tweet): Protocol design of EduStra-HF, a randomized controlled trial comparing intensive therapeutic education strategy conducted by nurses to usual care in patients with acute heart failure.
☆☆ X (Twitter) handle: @lsoulatdufour (L. Soulat-Dufour).
☆☆☆ The EduStra-HF investigators are listed in the Appendix A.


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 117 - N° 10

P. 561-568 - octobre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials?
  • Stéphane Manzo-Silberman, Gilles Montalescot, Guillaume Lebreton
| Artículo siguiente Artículo siguiente
  • Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort
  • David Sulman, Frederic Beaupré, Perrine Devos, Niki Procopi, Mathieu Kerneis, Paul Guedeney, Olivier Barthélémy, Anthony Elhadad, Stephanie Rouanet, Delphine Brugier, Guillaume Hekimian, Juliette Chommeloux, Alain Combes, Johanne Silvain, Jean-Philippe Collet, Gilles Montalescot, Michel Zeitouni, for the ACTION group

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.